INTRODUCTION
Among men, prostatic malignancy is one of the prevailing reasons of cancer related mortality and morbidity. 1 Beside pain and mortality, it may also present with acute urinary retention, haematuria, bladder calculi and upper urinary tract hydronephrosis. 2 The computed incidence of urinary retention in locally advanced prostate cancer was around 13%. 3 In pre-PSA (prostate specific antigen) era bladder obstructive symptom was primary presentation in 82% of prostatic carcinoma patients. 4 Cohort of these patients require treatment to ameliorate their symptoms and to reduce further complications. Numerous treatment options are used for these purposes like antiandrogen therapy, catheterization, laser therapy, prostatic stent or palliative TURP. metastatic cancer to relieve bladder outlet obstructive symptoms and complications. 8 It is most commonly used treatment and it offers quickest relief of symptoms.
Different drugs and new radiation methods are also used to manage advance prostatic malignancy. However, in this rapidly evolving era of new drugs like docetaxel, cabazitaxel, abiraterone, enzalutamide and radium 223, there is paucity of literature about outcome and complication of pTURP. Additionally, there is scarcity of literature in Indian scenario too. So, author did single centre indication (of surgery) matched retrospective case control study to know functional outcomes and morbidity of pTURP in eastern Indian population.
METHODS
Author did retrospective review of patients who underwent pTURP during period of January 2013 to January 2018. The patient with associated urethral stricture, patients who underwent re-surgery, patients who had taken pelvic radiotherapy were excluded. Indications of procedure of pTURP were noted. According to indication of pTURP, stratification of control patients (who underwent TURP for benign disease) were done. Among stratified group equal number of patients were selected as control with help of computer generated stratified randomized number. Variables like age, prostatic size, operative time, transurethral resection syndrome, blood transfusion, requirement of intensive care admission etc. were recorded in both case and control patients. Functional outcome of pTURP were further grouped into favourable and unfavourable outcomes. Unfavourable outcomes were patients who could not be catheter free, require re-pTURP, developed stricture or incontinence. Author also tried to find factors that might be associated with unfavourable outcomes.
Data were analysed with SPSS 23. Two tailed Fisher exact test and Mann-Whitney test were applied where required. P value less than 0.05 was considered statistically significant.
RESULTS
Total of 37 patients underwent pTURP during study period. Among them 29 patients were included, and 8 patients were excluded (3 patients had taken radiotherapy for advanced prostatic malignancy, 4 patients underwent Re-TURP and 1 had urethral stricture disease). Indication of procedure was absolute like refractory urinary retention (n18), upper tract hydronephrosis (resolved after catheterization, n 10) and refractory haematuria (prostate related, n 1). About 188 patients underwent TURP for similar indication but due to benign prostatic enlargement. Among 188 patients, 29 patients were selected as control on basis of stratified randomization. Patients of pTURP arm were older (74.55±8.28years of pTURP arm vs 69.13±8.52 of TURP arm, p<0.001) compared to TURP arm. Prostatic volume (ml), duration of operative procedure (min), post-operative hospital stays (days), post-operative catheter duration (days) and post -op maximum flow rate (ml/min) of pTURP groups were 64.20±9.96, 54.55±15.66, 4.51±3.56, 4.79±15.74 and 14.07±7.38 respectively. These parameters are statistically similar to TURP group (Table 1) . Higher PSA, longer operative time and hormone refractory metastatic prostatic carcinoma were found to be associated with unfavourable outcome (Table 3) . 
DISCUSSION
Despite of various options like antiandrogen therapy, catheterisation, laser therapy and prostatic stent, pTURP is most commonly employed modality to treat bladder outlet obstruction. pTURP is procedure to remove only obstructing part of prostatic tissue to make channel in the background of prostatic malignancy, so it is also called channel TURP. Incomplete removal and probable resection of malignant tissue may alter outcome and produce complication.
So, offering pTURP to patient we need to know functional outcome and complication. pTURP was primarily studied including 41 patients (mean age 74years) by Mazur AW et al. 8 They found excellent early post-operative outcome with no peri-operative mortality, 27% re-operation and 7% stress incontinence. Recent study done by Chang CC et al, also showed good result of TURP outcome, which was done for diagnosed prostate cancer or prostate cancer diagnosed after procedure. 9 Mean age of patients who underwent pTURP was 75.8years. No peri-operative death, no TURP syndrome was noted. However, 16.7% failed initial voiding and 29 % re-operation was noted.
Marszalek M et al, had reviewed retrospectively 89 patients (mean age 75.9years and mean prostatic volume 62ml), who underwent pTURP. 10 They observed 96% patients discharged catheter free, no blood transfusion required in 81 patients (out of 89), 2.2% peri-operative mortality and 21% mortality in 3years.
They concluded that pTURP is safe and effective procedure with potential adverse impact on survival. In present retrospective study, 29 patients were included. Age (mean 75.74years) and prostatic volume (64.20cc) was like previous study. 6 No TURP syndrome or perioperative mortality was seen. 75.86 % patient voided after first voiding trial while finally 96.55% patients voided after giving second voiding trial in remaining.
First failed initial voiding (17.24%) was similar to Chang CC et al study (16.7%) but lower from Crain DS et al. study (42%). 17.21% patients required re-operation in this study. Re-operation rate was lower from previous study (17.21% in present study vs 22%-29% in previous study). 8, 9, 11 Probable reason was exclusion of patients who had taken radiotherapy.
One patient developed persistence incontinence, who further opted for continuous catheterization. Operative procedure of that patient showed involvement of external sphincter with tumour. Similar complication was noted by Mazur AW et al, in pTURP for sphincteric involved prostatic malignancy. 8 Overall, present study showed good outcome with comparable complication with previous study. Due to limited retrospective study we also did comparative study to know functional outcome and complication with respect to TURP done for benign disease. Despite of significantly older population of pTURP group of patients, outcome in term of operative time, catheter free status and post-operative mean flow rate were like TURP group.
In both arm no TURP syndrome or peri-operative mortality were noted. However, statistically similar but clinically more complication was noted in pTURP arm in terms of failed voiding trial, incontinence and reoperation rate. Explanation of this was older age and incomplete resection in pTURP group. One capsular tear was noted only in TURP arm. Resection of gland upto capsule in TURP for benign prostatomegaly was probable reason. 11 Comprehensively, comparative result of outcome and complication of pTURP and TURP arm reflect that pTURP is safe and effective procedure as TURP. Unfavorable outcome was noted among 8 out of 29 patients, favourable outcome was achieved in 22 patients. 8 patients developed unfavorable outcome (1 persistent incontinence, 5 needed re-surgery and 2 required recatheterization in follow up period). Higher PSA and longer operative time were found to be associated with unfavorable outcome.
In this study, unfavorable outcome was less from previous study (27.58% unfavorable outcome in present study vs 36.95% unfavorable outcome in previous study), but hormone refractory status, predictor of bad outcome is similar to previous study. 12 Hormone refractory status and additionally, long operative time and PSA are also higher in patients of unfavourable group. Study done to know outcome and complication of pTURP for prostate cancer in India is scanty and present study comprises fairly good number of patients of Indian Ethnicity. In present study, author also evaluated risk factors that may hamper good outcome.
CONCLUSION
Decisively, author concluded that pTURP was safe and effective procedure to relieve bladder outlet obstruction. Hormone refractory status, higher PSA and prolonged operative time may be risk factors of poor outcome. However prospective and multicentric study may clearly identify risk factor of poor outcome.
